Taiwan FDA registration a03414645b07dcae33ae2975d5368d29
EBV early antigen IgG antibody test group
TW: EB 病毒早期抗原 IgG抗體測試組
Taiwan·IBL SOCIETY OF IMMUNOCHEMISTRY AND IMMUNOBIOLOGY MBH·Registered Nov 14, 2005 – Nov 14, 2010CancelledRegistration details
- Analysis ID
- a03414645b07dcae33ae2975d5368d29
- Customs Code
- DHA00601465305
Company information
- Manufacturer Country
- Germany
- Authorized Representative
- Dachen Biotechnology Co., Ltd
Product details
- Intended Use
- Enzyme immunoassay was used to quantitatively and quantitatively detect IgG antibodies against early antigen (EA) of Epstein Barr virus in human serum and plasma.
- Product Type (Level 1)
- C Immunology and microbiology
- Import Information
- import
Dates and status
- Registration Date
- Nov 14, 2005
- Expiry Date
- Nov 14, 2010
- Cancellation Date
- Nov 06, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for EBV early antigen IgG antibody test group in Taiwan's medical device market through Pure Global AI's free database. is registered under number a03414645b07dcae33ae2975d5368d29 and manufactured by IBL SOCIETY OF IMMUNOCHEMISTRY AND IMMUNOBIOLOGY MBH. The authorized representative in Taiwan is Dachen Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices